Abstract
Psoriasis cellular hallmarks, such as the imbalance between Th1/Th17 and Th2 cytokines and the dysregulated expression of vascular endothelial growth factor (VEGF), inducible nitric oxide synthase, (iNOS) and indoleamine 2,3-dioxygenase (IDO), are all detectable in mesenchymal stem cells (MSCs) suggesting that psoriasis originates at mesenchymal level. In this scenario, MSCs may become the new therapeutic target and interest in the effects of traditionally used drugs, such as Apremilast, on MSCs has greatly increased. MSCs from control subjects (C-MSCs) and from psoriatic patients before (PsO MSCs T0) and after in vivo treatment with Apremilast (PsO-MSCs T12) were isolated and characterized; subsequently, the effects of Apremilast on VEGF, iNOS and IDO expression were evaluated by immunocytochemistry (ICC). The expression of VEGF, iNOS and IDO was also detected in skin sections by immunohistochemistry (IHC). The results indicate that in vivo administration of Apremilast is able to drive the altered profile of PsO-MSCs towards a more physiological pattern. In skin sections, the role of Apremilast is evident in reducing VEGF, iNOS and IDO expression. Apremilast treatment influences the expression of VEGF, iNOS and IDO not only by...Continue Reading
References
Dec 5, 1998·Biochemical and Biophysical Research Communications·J Kroll, J Waltenberger
Jul 28, 2004·Nitric Oxide : Biology and Chemistry·M-M Cals-Grierson, A D Ormerod
Nov 16, 2004·Journal of Dermatological Science·Mikito ItoChisei Ra
Aug 23, 2006·Cytotherapy·M DominiciEm Horwitz
Apr 19, 2008·Current Medical Research and Opinion·A B GottliebC Kipnis
Feb 4, 2009·Journal of Dermatological Science·Oriana SimonettiAnnamaria Offidani
May 1, 2009·Arthritis and Rheumatism·Gabriel CriadoRichard O Williams
Jul 1, 2009·International Journal of Experimental Pathology·Regina HeidenreichKamran Ghoreschi
Jan 7, 2010·British Journal of Pharmacology·P H SchaferD I Stirling
May 7, 2010·The Journal of Investigative Dermatology·Batya B DavidoviciJames G Krueger
Jun 1, 2011·The British Journal of Dermatology·M OrcianiR Di Primio
Jun 29, 2011·The International Journal of Developmental Biology·Domenico RibattiEnrico Crivellato
Aug 26, 2011·Dermatology : International Journal for Clinical and Investigative Dermatology·P QuaglinoM G Bernengo
Oct 11, 2011·Journal of Inflammation·Linnéa AspHåkan Karlsson
Feb 24, 2012·The British Journal of Dermatology·A CampanatiA Offidani
Jul 31, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stefania MerighiPier Andrea Borea
Oct 1, 2010·Therapeutic Advances in Musculoskeletal Disease·Georg SchettPeter Schafer
May 24, 2014·Journal of Vascular Research·Peter C StaporWalter Lee Murfee
Aug 28, 2014·Archives of Dermatological Research·A CampanatiA Offidani
Feb 3, 2015·Journal of Cellular Biochemistry·Diba SheipouriNady Braidy
Jun 26, 2015·PloS One·Roberta MancusoMario Clerici
Jun 4, 2016·The British Journal of Dermatology·M Llamas-VelascoE Daudén
Oct 25, 2016·Experimental Dermatology·Anna CampanatiAnnamaria Offidani
Sep 18, 2016·The British Journal of Dermatology·M OrcianiR Di Primio
Sep 30, 2016·The Journal of International Medical Research·Anna CampanatiAnnamaria Offidani
Jan 27, 2017·International Journal of Molecular Sciences·Tae-Hoon ShinKyung-Sun Kang
Mar 17, 2017·The British Journal of Dermatology·S Trabanelli
Apr 21, 2018·Clinical and Experimental Immunology·A CampanatiA Offidani
Aug 25, 2018·JAMA Dermatology·Anna CampanatiRoberto Di Primio